Allianz Asset Management Gmb H T2 Biosystems, Inc. Transaction History

Allianz Asset Management Gmb H

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$0.58 - $3.01 $280,070 - $1.45 Million	-482,881 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$1.47 - $3.16 $5,450 - $11,717	-3,708 Reduced 0.76%	482,881 $811,000
Q1 2019 May 13, 2019	BUY	$2.56 - $4.48 $58 - $103	23 Added 0.0%	486,589 $1.28 Million
Q4 2018 Feb 14, 2019	SELL	$2.98 - $6.86 $66,451 - $152,971	-22,299 Reduced 4.38%	486,566 $1.47 Million
Q3 2018 Nov 13, 2018	BUY	$5.36 - $7.83 $708,736 - $1.04 Million	132,227 Added 35.11%	508,865 $3.79 Million
Q2 2018 Aug 13, 2018	BUY	$5.97 - $9.58 $2.25 Million - $3.61 Million	376,638 New	376,638 $2.92 Million

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.